AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
36.43
-0.15 (-0.41%)
Nov 3, 2025, 10:10 AM EST - Market open
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.02 billion as of November 3, 2025. Its market cap has increased by 7.11% in one year.
Market Cap
1.02B
Enterprise Value
1.10B
1-Year Change
7.11%
Ranking
Category
Stock Price
$36.43
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.02B, an increase of 230.39%. That is a compound annual growth rate of 14.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 1.02B | 154.18% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |